These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22318512)

  • 21. Cilnidipine improves insulin sensitivity in the Otsuka Long-Evans Tokushima fatty rat, a model of spontaneous NIDDM.
    Harada N; Ohnaka M; Sakamoto S; Niwa Y; Nakaya Y
    Cardiovasc Drugs Ther; 1999 Nov; 13(6):519-23. PubMed ID: 10686661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal renal structural alterations during the development of diabetes mellitus in Otsuka Long-Evans Tokushima Fatty rats.
    Koike T; Tomoda F; Kinuno H; Inoue H; Takata M
    Acta Physiol Scand; 2005 May; 184(1):73-81. PubMed ID: 15847646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of combined olmesartan and pravastatin on glucose intolerance and cardiovascular remodeling in a metabolic-syndrome model.
    Mizukawa M; Ohmori K; Obayashi A; Ishihara Y; Yoshida J; Noma T; Yukiiri K; Kosaka H; Kohno M
    Hypertens Res; 2009 Jul; 32(7):617-24. PubMed ID: 19461650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of microalbuminuria in patients with type 2 diabetes and hypertension.
    Menne J; Izzo JL; Ito S; Januszewicz A; Katayama S; Chatzykirkou C; Mimran A; Rabelink TJ; Ritz E; Ruilope LM; Rump LC; Viberti G; Haller H;
    J Hypertens; 2012 Apr; 30(4):811-8; discussion 818. PubMed ID: 22418908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron restriction prevents diabetic nephropathy in Otsuka Long-Evans Tokushima fatty rat.
    Matsumoto M; Sasaki N; Tsujino T; Akahori H; Naito Y; Masuyama T
    Ren Fail; 2013 Sep; 35(8):1156-62. PubMed ID: 23902566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of intrarenal angiotensin-converting enzyme in nephropathy of type II diabetic rats.
    Taniguchi M; Kim S; Zhan Y; Iwao H
    Hypertens Res; 2002 Mar; 25(2):287-94. PubMed ID: 12047045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olmesartan, microalbuminuria, and type 2 diabetes.
    Fioretto P; Mauer M
    N Engl J Med; 2011 Jun; 364(23):2260-1; author reply 2262-3. PubMed ID: 21651400
    [No Abstract]   [Full Text] [Related]  

  • 28. The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) observational follow-up study: benefits of RAS blockade with olmesartan treatment are sustained after study discontinuation.
    Menne J; Ritz E; Ruilope LM; Chatzikyrkou C; Viberti G; Haller H
    J Am Heart Assoc; 2014; 3(2):e000810. PubMed ID: 24772521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular proliferation and transforming growth factor-beta expression in pre- and early stage of diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats.
    Hosomi N; Noma T; Ohyama H; Takahashi T; Kohno M
    Atherosclerosis; 2002 May; 162(1):69-76. PubMed ID: 11947899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Olmesartan, microalbuminuria, and type 2 diabetes.
    Yudkin JS; Lehman R
    N Engl J Med; 2011 Jun; 364(23):2260; author reply 2262-3. PubMed ID: 21651401
    [No Abstract]   [Full Text] [Related]  

  • 31. Olmesartan, microalbuminuria, and type 2 diabetes.
    Lammert A; Krämer BK; Krüger B
    N Engl J Med; 2011 Jun; 364(23):2261; author reply 2262-3. PubMed ID: 21651399
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of glomerular lesion and abnormal urinary findings in OLETF rats resulting from a long-term diabetic state.
    Fukuzawa Y; Watanabe Y; Inaguma D; Hotta N
    J Lab Clin Med; 1996 Dec; 128(6):568-78. PubMed ID: 8960640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renin-angiotensin blockade resets podocyte epigenome through Kruppel-like Factor 4 and attenuates proteinuria.
    Hayashi K; Sasamura H; Nakamura M; Sakamaki Y; Azegami T; Oguchi H; Tokuyama H; Wakino S; Hayashi K; Itoh H
    Kidney Int; 2015 Oct; 88(4):745-53. PubMed ID: 26108068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal hemodynamics in Otsuka Long-Evans Tokushima fatty rat, a model rat of spontaneous non-insulin-dependent diabetes mellitus with obesity.
    Uriu K; Kaizu K; Qie YL; Kai K; Ito A; Ikeda M; Hashimoto O; Sun XF; Morita E; Eto S
    J Lab Clin Med; 1999 Nov; 134(5):483-91. PubMed ID: 10560942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal autoregulation and tubuloglomerular feedback in prediabetic and diabetic OLETF rats.
    Hashimoto S; Yamada K; Kawata T; Mochizuki T; Schnermann J; Koike T
    Am J Physiol Renal Physiol; 2009 Mar; 296(3):F598-604. PubMed ID: 19106213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Rho-kinase inhibitor, fasudil, prevents development of diabetes and nephropathy in insulin-resistant diabetic rats.
    Kikuchi Y; Yamada M; Imakiire T; Kushiyama T; Higashi K; Hyodo N; Yamamoto K; Oda T; Suzuki S; Miura S
    J Endocrinol; 2007 Mar; 192(3):595-603. PubMed ID: 17332527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preemptive olmesartan for the delay or prevention of microalbuminuria in diabetes.
    Ingelfinger JR
    N Engl J Med; 2011 Mar; 364(10):970-1. PubMed ID: 21388316
    [No Abstract]   [Full Text] [Related]  

  • 38. The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease.
    Yanagi M; Tamura K; Fujikawa T; Wakui H; Kanaoka T; Ohsawa M; Azushima K; Maeda A; Kobori H; Umemura S
    Hypertens Res; 2013 Mar; 36(3):262-9. PubMed ID: 23154587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of heat-processed ginseng and its active component ginsenoside 20(S)-Rg3 on the progression of renal damage and dysfunction in type 2 diabetic Otsuka Long-Evans Tokushima Fatty rats.
    Kang KS; Yamabe N; Kim HY; Park JH; Yokozawa T
    Biol Pharm Bull; 2010; 33(6):1077-81. PubMed ID: 20522983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detailed localization of augmented angiotensinogen mRNA and protein in proximal tubule segments of diabetic kidneys in rats and humans.
    Kamiyama M; Garner MK; Farragut KM; Sofue T; Hara T; Morikawa T; Konishi Y; Imanishi M; Nishiyama A; Kobori H
    Int J Biol Sci; 2014; 10(5):530-42. PubMed ID: 24910532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.